Viking Therapeutics (VKTX) Stock Forecast & Price Target

$65.98

+1.30 (+2.01%)

(As of 07/26/2024 ET)

Viking Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 10 Analyst Ratings

Based on 10 Wall Street analysts who have issued ratings for Viking Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 10 analysts, 9 have given a buy rating, and 1 has given a strong buy rating for VKTX.

Consensus Price Target

$111.78
69.41% Upside

High Forecast	$138.00
Average Forecast	$111.78
Low Forecast	$80.00

According to the 10 analysts' twelve-month price targets for Viking Therapeutics, the average price target is $111.78. The highest price target for VKTX is $138.00, while the lowest price target for VKTX is $80.00. The average price target represents a forecasted upside of 69.41% from the current price of $65.98.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	10 Buy rating(s)	9 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$111.78	$111.56	$112.25	$30.25
Forecasted Upside	69.41% Upside	66.97% Upside	47.30% Upside	81.52% Upside

Get Viking Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

VKTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VKTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Viking Therapeutics Stock vs. The Competition

Type	Viking Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.10	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	69.41% Upside	3,123.38% Upside	9.16% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/25/2024	Raymond James 4 of 5 stars	S. Seedhouse Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Strong-Buy ➝ Strong-Buy	$116.00 ➝ $118.00	+76.67%
7/25/2024	HC Wainwright 3 of 5 stars		Reiterated Rating	Buy ➝ Buy	$90.00 ➝ $90.00	+78.54%
6/27/2024	Morgan Stanley 3 of 5 stars		Initiated Coverage	Overweight	$105.00	+121.57%
6/17/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$120.00 ➝ $120.00	+135.71%
6/4/2024	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$120.00 ➝ $120.00	+117.08%
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$116.00 ➝ $138.00	+63.55%
Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
3/26/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $125.00	+47.58%
3/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$80.00	+23.36%
3/7/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$110.00	+20.64%
2/23/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
5/30/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dupuis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
3/29/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$15.00 ➝ $19.00	+18.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:15 AM ET.

VKTX Forecast - Frequently Asked Questions

What is Viking Therapeutics' forecast for 2024?: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Viking Therapeutics is $111.78, with a high forecast of $138.00 and a low forecast of $80.00.
Should I buy or sell Viking Therapeutics stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viking Therapeutics in the last year. There are currently 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VKTX shares.
Does Viking Therapeutics's stock price have much upside?: According to analysts, Viking Therapeutics's stock has a predicted upside of 68.82% based on their 12-month stock forecasts.
Has Viking Therapeutics been upgraded by Wall Street analysts recently?: Over the previous 90 days, Viking Therapeutics's stock had 1 upgrade by analysts.
What analysts cover Viking Therapeutics?: Viking Therapeutics has been rated by research analysts at HC Wainwright, Maxim Group, Morgan Stanley, Raymond James, and Truist Financial in the past 90 days.
Do Wall Street analysts like Viking Therapeutics more than its competitors?: Analysts like Viking Therapeutics more than other "medical" companies. The consensus rating for Viking Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VKTX compares to other companies.